title: Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.
abstract: We tested whether proteins implicated in Huntington's and other polyglutamine (polyQ) expansion diseases can cause axonal transport defects. Reduction of Drosophila huntingtin and expression of proteins containing pathogenic polyQ repeats disrupt axonal transport. Pathogenic polyQ proteins accumulate in axonal and nuclear inclusions, titrate soluble motor proteins, and cause neuronal apoptosis and organismal death. Expression of a cytoplasmic polyQ repeat protein causes adult retinal degeneration, axonal blockages in larval neurons, and larval lethality, but not neuronal apoptosis or nuclear inclusions. A nuclear polyQ repeat protein induces neuronal apoptosis and larval lethality but no axonal blockages. We suggest that pathogenic polyQ proteins cause neuronal dysfunction and organismal death by two non-mutually exclusive mechanisms. One mechanism requires nuclear accumulation and induces apoptosis; the other interferes with axonal transport. Thus, disruption of axonal transport by pathogenic polyQ proteins could contribute to early neuropathology in Huntington's and other polyQ expansion diseases.
authors.affiliation: Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
authors.forename: Shermali
authors.initials: S
authors.lastname: Gunawardena
authors.forename: Lu-Shiun
authors.initials: LS
authors.lastname: Her
authors.forename: Richard G
authors.initials: RG
authors.lastname: Brusch
authors.forename: Robert A
authors.initials: RA
authors.lastname: Laymon
authors.forename: Ingrid R
authors.initials: IR
authors.lastname: Niesman
authors.forename: Beth
authors.initials: B
authors.lastname: Gordesky-Gold
authors.forename: Louis
authors.initials: L
authors.lastname: Sintasath
authors.forename: Nancy M
authors.initials: NM
authors.lastname: Bonini
authors.forename: Lawrence S B
authors.initials: LS
authors.lastname: Goldstein
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D001370:Axonal Transport / Q000502:physiology*; D016923:Cell Death / Q000502:physiology; D004330:Drosophila; D029721:Drosophila Proteins / Q000096:biosynthesis / Q000172:deficiency* / Q000235:genetics; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology; D006801:Humans; D000071058:Huntingtin Protein; D006816:Huntington Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008297:Male; D009419:Nerve Tissue Proteins / Q000096:biosynthesis / Q000172:deficiency* / Q000235:genetics; D009687:Nuclear Proteins / Q000096:biosynthesis / Q000172:deficiency* / Q000235:genetics; D010455:Peptides / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D010641:Phenotype
chemical_list: D029721:Drosophila Proteins; C086055:HTT protein, human; D000071058:Huntingtin Protein; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D010455:Peptides; C097188:polyglutamine